Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ignatia amara is a homeopathic remedy prepared from the seeds of the Strychnos ignatii plant (commonly called "Ignatius bean"). It is primarily used in homeopathy for relief of emotional distress such as grief, anxiety, hypersensitivity to stress and mood swings. The seeds contain alkaloids including strychnine and brucine that affect the nervous system by influencing nerve impulse transmission to muscles. In homeopathic preparations (high dilutions), it is claimed to help with symptoms like apprehension, irritability, sadness or moodiness often associated with emotional disturbances[1][2][3][4][5]. The product is available as oral pellets or tinctures and marketed for both adults and children. Despite its use in homeopathy at high dilutions considered non-toxic by practitioners[1], the raw plant material itself contains toxic compounds and can be dangerous if ingested directly[7]. There are no established mechanisms of action recognized in conventional pharmacology due to its extreme dilution in homeopathic products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ignatia amara.